Events & Training for January 2020

Pre-Filled Syringes and Injectable Drug Devices 2020

15 January 2020 - 16 January 2020

Assessing the regulatory environment and future of PFS design and development SMi are pleased to present the 12th Annual Pre-Filled Syringes and Injectable Drug Devices conference in London on 15th and 16th January 2020. As Europe’s leading Pre-Filled Syringes conference, the 2020 event will assess innovations in device engineering and components, enhancement of human factors, and optimizing packaging and containment. With the rapid expansion of the PFS market, the regulatory environment is more importance than ever. This year’s programme will look at the EU MDR, Article 117 as well as insights into the MDR post-market surveillance requirements; providing a holistic review of the Pre-Filled Syringes industry. This two-day agenda offers you peer-to-peer networking with Global Product Managers, Senior Pre-Filled Syringes Engineers, Device Testing Managers, Heads of Late-Stage Pre-Filled Syringes Development, Head of Medical Affairs, Senior Director – Combination Products & Medical Devices, Global Regulatory Affairs, Quality Assurance Manager Combination Products ,Senior Pharmaceutical Assessor and many more.

Copthorne Tara Hotel, London, UK

Pre-Filled Syringes and Injectable Drug Devices 2020

15 January 2020 - 16 January 2020

Assessing the regulatory environment and future of PFS design and development SMi are pleased to present the 12th Annual Pre-Filled Syringes and Injectable Drug Devices conference in London on 15th and 16th January 2020. As Europe’s leading Pre-Filled Syringes conference, the 2020 event will assess innovations in device engineering and components, enhancement of human factors, and optimizing packaging and containment. With the rapid expansion of the PFS market, the regulatory environment is more importance than ever. This year’s programme will look at the EU MDR, Article 117 as well as insights into the MDR post-market surveillance requirements; providing a holistic review of the Pre-Filled Syringes industry. This two-day agenda offers you peer-to-peer networking with Global Product Managers, Senior Pre-Filled Syringes Engineers, Device Testing Managers, Heads of Late-Stage Pre-Filled Syringes Development, Head of Medical Affairs, Senior Director – Combination Products & Medical Devices, Global Regulatory Affairs, Quality Assurance Manager Combination Products ,Senior Pharmaceutical Assessor and many more.

Copthorne Tara Hotel, London, UK

SMi’s 9th Annual Pharmaceutical Microbiology Conference

20 January 2020 - 21 January 2020

Pharmaceutical Microbiology as an industry is projected to see significant advancements in the next five years. This forecast is largely attributed to rapid microbiology testing, which has accounted for $3.5 billion last year, while projected to reach nearly double at $6 billion by 2025, and an estimated CAGR of 8.3% leading up to 2025. At the very core of pharmaceutical microbiology is the accurate and reliable detection of microorganisms that would otherwise contaminate the pharmaceutical products manufactured. This demand for more rapid methods for detection and identification will be accompanied by equally important areas such as: contamination control strategies and environmental monitoring, process automation, and discussing updates to meet regulatory requirements. Join us at SMi’s 9th Annual Pharmaceutical Microbiology Conference to explore novel and developing technologies that tackle the most pressing challenges and push innovation in world of pharmaceutical microbiology. #SMiPharmaMicroUK

Copthorne Tara Hotel, London, UK

Disruptive Technologies in Pharma

20 January 2020 - 21 January 2020

McKinsey estimates that big data and machine learning could generate up to $100bn in pharma and medicine annually. There has never been a more pressing need for pharma to transition to digital as existing technologies are being disrupted by Artificial Intelligence, Machine Learning, Virtual Reality, Internet of Things and Blockchain, while newer categories such as Prescription Digital Therapeutics begin to offer truly disruptive benefits. As new technologies are being incorporated into pharma it is crucial, we reflect on trends in cutting-edge innovation and explore new tech-enabled opportunities to cut costs and save time. Partnerships are at the heart of digital transformation. Innovative approaches to partnerships are leading the way towards more effective data collection, faster R&D, seamless clinical trials and above all, more patient-centric medicine.

Holiday Inn Kensington Forum, London, UK

Festival of Genomics and Biodata

29 January 2020 - 30 January 2020

The Festival is not like other genomics events, and neither is it meant to be. The early idea was “Woodstock for Genomics” … to bring people together, inspire them and leave them buzzing with energy and ideas – but also entertained. So that they leave with an increased motivation and the capability to better use genomics and related technologies. Ultimately, we want to make sure that patients benefit.

The Business Design Centre, 52 Upper Street, London, N1 0QH

The antibody revolution by Sir Gregory Winter: The 2020 Jephcott Lecture

05 February 2020

Molecular biologist and Nobel Prize winner Sir Gregory Winter will give this year’s Jephcott Lecture at the RSM. Exploring the theme ‘The antibody revolution’ Sir Gregory will describe how in recent years antibodies have emerged as a new class of pharmaceutical drugs. Many of the best-selling and most expensive pharmaceutical drugs are now antibodies, particularly for treatment of auto-immune inflammatory conditions such as rheumatoid arthritis and cancer. He will go onto discuss how continuing technology development is opening up new prospects for treatment of disease by antibodies and by small antibody mimics.

Royal Society of Medicine 1 Wimpole Street, London, W1G 0AE